On the Chameleonic Behaviour of Cholesterol through a Fractal/Multifractal Model.
Journal
Computational and mathematical methods in medicine
ISSN: 1748-6718
Titre abrégé: Comput Math Methods Med
Pays: United States
ID NLM: 101277751
Informations de publication
Date de publication:
2020
2020
Historique:
received:
26
01
2019
revised:
26
11
2019
accepted:
07
12
2019
entrez:
16
5
2020
pubmed:
16
5
2020
medline:
20
4
2021
Statut:
epublish
Résumé
An increasing number of studies are beginning to show that both low-density lipoprotein and high-density lipoprotein cholesterol can constitute risk factors for myocardial infarction. Such a behaviour has been called by experts in the field the "chameleonic effect" of cholesterol. In the present paper, a fractal/multifractal model for low-density lipoprotein and high-density lipoprotein cholesterol dynamics is proposed. In such a context, a fractal/multifractal tunneling effect for systems with spontaneous symmetry breaking is analyzed so that if the spontaneous symmetry breaking is assimilated to an inflammation (in the form of a specific scalar potential), then a coupling between two fractal/multifractal states can be observed. These two states, which have been associated to biological structures such as low-density lipoprotein and high-density lipoprotein, transfer their states through a fractal/multifractal tunneling effect. Moreover, in our opinion, the widely used notions of "good" and "bad" cholesterol must be redefined as two different states (low-density lipoprotein and high-density lipoprotein) of the same biological structure named "cholesterol." In our work, for the first time in the specialized literature, low-density lipoprotein and high-density lipoprotein have been regarded as two different states of the same biological structure (named "cholesterol"), such as in nuclear physics, the neutron and proton are two different states of the same particle named nucleon.
Identifiants
pubmed: 32411284
doi: 10.1155/2020/6217691
pmc: PMC7199616
doi:
Substances chimiques
Biomarkers
0
Cholesterol, HDL
0
Cholesterol, LDL
0
Cholesterol
97C5T2UQ7J
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
6217691Informations de copyright
Copyright © 2020 Nicolae Dan Tesloianu et al.
Déclaration de conflit d'intérêts
The authors declare that there are no conflicts of interest regarding the publication of this paper.
Références
JAMA. 2009 Nov 11;302(18):1993-2000
pubmed: 19903920
Trends Cardiovasc Med. 2001 Apr-May;11(3-4):155-61
pubmed: 11686006
Eur Heart J. 2017 Aug 21;38(32):2478-2486
pubmed: 28419274
Lancet. 2005 Oct 8;366(9493):1267-78
pubmed: 16214597
J Clin Invest. 2003 Jun;111(12):1795-803
pubmed: 12813012
Arthritis Rheum. 2012 Jun;64(6):1828-37
pubmed: 22231638
Ann Biomed Eng. 2010 Mar;38(3):1188-203
pubmed: 20087775
J Clin Invest. 1995 Dec;96(6):2758-67
pubmed: 8675645
J Am Heart Assoc. 2014 Mar 13;3(2):e000519
pubmed: 24627418
N Engl J Med. 2008 Mar 20;358(12):1240-9
pubmed: 18354102
BMJ Open. 2016 Jun 12;6(6):e010401
pubmed: 27292972
Nat Genet. 2008 Feb;40(2):161-9
pubmed: 18193043
Rom J Morphol Embryol. 2014;55(3 Suppl):1099-104
pubmed: 25607391
Eur Heart J. 2015 Nov 14;36(43):3017-9
pubmed: 26377399
Lancet. 2007 Dec 1;370(9602):1829-39
pubmed: 18061058
N Engl J Med. 2007 Nov 22;357(21):2109-22
pubmed: 17984165
N Engl J Med. 2006 Mar 23;354(12):1264-72
pubmed: 16554528
Anatol J Cardiol. 2017 Aug;18(2):155-157
pubmed: 28766510
Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):481-8
pubmed: 11304461
JAMA. 2008 Jun 4;299(21):2524-32
pubmed: 18523221
Ann Rheum Dis. 2012 Jul;71(7):1157-62
pubmed: 22267330
Eur Heart J. 2015 Nov 14;36(43):3007-16
pubmed: 26248570
Front Physiol. 2010 Jul 06;1:15
pubmed: 21423358
Lancet. 2012 Aug 11;380(9841):572-80
pubmed: 22607825
JAMA. 2001 May 16;285(19):2486-97
pubmed: 11368702
Arterioscler Thromb Vasc Biol. 2018 Sep;38(9):2236-2244
pubmed: 30026268